Metraipolis › archive › dc_119ae23de92a

Advancements in the utilization of immune checkpoint inhibitors for the treatment of gynecological tumors — Europe PMC PMID:41983132

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41983132
DOI
10.3389/fimmu.2026.1686568
License (as archived)
solo-consultazione
Archived
2026-11-03T16:21:44.831Z
SHA-256 of the archived text
31d9a36b797a0e78121f6883cdb49db8c1f694dfeedb2a53115b97c9cf33d6c9
Stable URL of this page
https://metraipolis.com/documento/dc_119ae23de92a

How to cite

Advancements in the utilization of immune checkpoint inhibitors for the treatment of gynecological tumors — Europe PMC PMID:41983132 — Europe PMC (en), https://europepmc.org/article/MED/41983132 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_119ae23de92a (Metraipolis archive dc_119ae23de92a, sha256 31d9a36b797a0e78121f6883cdb49db8c1f694dfeedb2a53115b97c9cf33d6c9)
BibTeX
@misc{dc119ae23de92a,
  title = {Advancements in the utilization of immune checkpoint inhibitors for the treatment of gynecological tumors — Europe PMC PMID:41983132},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41983132},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_119ae23de92a; sha256 31d9a36b797a0e78121f6883cdb49db8c1f694dfeedb2a53115b97c9cf33d6c9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41983132. Agents can read the archived copy with the MCP tool read_document.